Published in Ann Allergy Asthma Immunol on May 04, 2016
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med (2009) 21.74
Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm (2009) 7.43
The DRESS syndrome: a literature review. Am J Med (2011) 5.13
Clinical practice guidelines for antimicrobial prophylaxis in surgery. Am J Health Syst Pharm (2013) 5.02
Drug-induced acute interstitial nephritis. Kidney Int (2001) 2.96
Systematic review and meta-analysis of vancomycin-induced nephrotoxicity associated with dosing schedules that maintain troughs between 15 and 20 milligrams per liter. Antimicrob Agents Chemother (2012) 2.15
Nephrotoxicity of vancomycin, alone and with an aminoglycoside. J Antimicrob Chemother (1990) 2.06
A retrospective analysis of possible renal toxicity associated with vancomycin in patients with health care-associated methicillin-resistant Staphylococcus aureus pneumonia. Clin Ther (2007) 2.05
Drug allergy: an updated practice parameter. Ann Allergy Asthma Immunol (2010) 2.00
Drug reaction with eosinophilia and systemic symptoms: a retrospective study of 60 cases. Arch Dermatol (2010) 1.99
Historical yearly usage of vancomycin. Antimicrob Agents Chemother (1998) 1.83
Evaluation of the efficacy and safety of outpatient parenteral antimicrobial therapy for infections with methicillin-sensitive Staphylococcus aureus. South Med J (2005) 1.64
Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study. Br J Dermatol (2013) 1.60
Antihistamine prophylaxis permits rapid vancomycin infusion. Crit Care Med (1999) 1.57
Chronic bullous disease of childhood, childhood cicatricial pemphigoid, and linear IgA disease of adults. A comparative study demonstrating clinical and immunopathologic overlap. J Am Acad Dermatol (1988) 1.54
Vancomycin and the red-man syndrome: pharmacodynamics of histamine release. J Infect Dis (1988) 1.35
Six-year retrospective review of drug reaction with eosinophilia and systemic symptoms. Acta Derm Venereol (2012) 1.28
Linear immunoglobulin A bullous dermatosis. Clin Dermatol (2011) 1.21
Emergency department diagnosis and treatment of anaphylaxis: a practice parameter. Ann Allergy Asthma Immunol (2014) 1.03
Vancomycin-induced hypersensitivity reaction with acute renal failure: resolution following cyclosporine treatment. Clin Nephrol (2005) 1.03
Risk stratification for desensitization of patients with carboplatin hypersensitivity: clinical presentation and management. J Allergy Clin Immunol (2009) 0.96
Clinical features, diagnosis, and pathogenesis of chronic bullous disease of childhood. Dermatol Clin (2011) 0.93
Vancomycin skin tests and prediction of "red man syndrome" in healthy volunteers. Antimicrob Agents Chemother (1993) 0.93
Vancomycin revisited - 60 years later. Front Public Health (2014) 0.93
DRESS syndrome caused by teicoplanin and vancomycin, associated with reactivation of human herpesvirus-6. Int J Dermatol (2007) 0.91
Rapid drug desensitization for hypersensitivity reactions to chemotherapy and monoclonal antibodies in the 21st century. J Investig Allergol Clin Immunol (2014) 0.90
Breakthrough reactions of iodinated and gadolinium contrast media after oral steroid premedication protocol. BMC Med Imaging (2014) 0.88
Biopsy-proved acute tubulointerstitial nephritis and toxic epidermal necrolysis associated with vancomycin. Pharmacotherapy (2001) 0.87
Biopsy-proven vancomycin-associated interstitial nephritis and acute tubular necrosis. Clin Exp Nephrol (2011) 0.84
The use of vancomycin with its therapeutic and adverse effects: a review. Eur Rev Med Pharmacol Sci (2015) 0.84
Diagnosing drug-induced AIN in the hospitalized patient: a challenge for the clinician. Clin Nephrol (2014) 0.83
Successful vancomycin desensitization with a combination of rapid and slow infusion methods. Intern Med (2006) 0.83
Vancomycin anaphylaxis in a patient with vancomycin-induced red man syndrome. Am J Ther (2000) 0.78
Vancomycin anaphylaxis and successful desensitization in a patient with end stage renal disease on hemodialysis by maintaining steady antibiotic levels. Ann Allergy Asthma Immunol (2000) 0.77
Acute cardiac and pulmonary arrest after infusion of vancomycin with subsequent desensitization. J Allergy Clin Immunol (1997) 0.77
Drug desensitization in the management of hypersensitivity reactions to monoclonal antibodies and chemotherapy. BioDrugs (2014) 0.77
Optimal management of DRESS syndrome in course of infectious endocarditis. Ann Allergy Asthma Immunol (2013) 0.76
Influences of everninomicin, vancomycin and teicoplanin on chemical mediator release from rat peritoneal mast cells. Jpn J Pharmacol (2000) 0.76
A role for vancomycin epicutaneous skin testing in the evaluation of perioperative anaphylaxis. J Allergy Clin Immunol Pract (2015) 0.76
Treatment Outcomes and Adverse Drug Reactions Associated with Ceftaroline Use. Open Forum Infect Dis (2015) 0.75